Amylin Heads to India for Diabetes Developments
By Taskin Ahmed
PharmaDeals Review: Vol 2009 Issue 9 (Table of Contents)
Published: 22 Sep-2009
DOI: 10.3833/pdr.v2009i9.1246 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Amylin Pharmaceuticals and Biocon are to collaborate on the development of Amylin’s phybrid technology for the treatment of diabetes...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login on the top right purple box.
Copyright: PharmaVentures Ltd
Login Problems
RSS